Parliamentary panel recommends DoP to consider Telangana model of sanitary pad distribution: Gireesh Babu, New Delhi Friday, January 24, 2025, 12:15 Hrs [IST] The Parliamentary pa ...

In 2021, Sun Pharma forayed into the nutrition ... Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd. Who is/are the promoter/promoters ...

Divis Laboratories set up another manufacturing plant in Kakinada, Andhra Pradesh in 2021. As of March 2022 ... Torrent Pharmaceuticals Ltd, Mankind Pharma Ltd, Dr Reddys Laboratories Ltd ...

Donald Trump gives his first speech as president at his inauguration to a front row filled with powerful and controversial people. We look at what he had to say.

Stay informed with Hindustan Times' live updates! Track the latest lifestyle news including fashion trends, style guide & ...

Shares of Mankind Pharma plunged nearly 6 percent on January 24, weighed down by a fall in the company's October-December net profit. The company's bottomline dropped over 16 percent on year in Q3 ...

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs.

Revenue from operations rose to Rs 3,230 crore from Rs 2,607 crore, Mankind Pharma said in a statement. "We achieved a healthy revenue growth of 24 per cent YoY with strong adjusted EBITDA margin of ...

- Per. of shares (as a % of the total sh. of prom. and promoter group)----- - Per. of shares (as a % of the total Share Cap. of the company)----- Advisory Alert: It has come to our attention ...

After a year in which the need for digital transformation in pharma reached white heat levels, the sector mustn’t cool off in 2021 and revert to business-as-usual. A return to normal is the ...

Mankind Pharma Ltd.'s share price declined more than 5% during early trade on Friday after the company's third-quarter results showed the consolidated net profit fell, missing analysts' estimates. The ...

Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread opioid ...